Cancer Stem Cells (CSCs) Market Trends, Research Report, Growth, Opportunities, Forecast 2022-2028

The global cancer stem cells (CSCs) market is anticipated to grow at a significant CAGR during the forecast period. Cancer stem cells (CSCs) are self-renewable cell types that are found in most types of liquid and solid cancers and are responsible for tumor beginning, its growth, resistance, recurrence, and metastasis after therapy. CSCs are identified from the expression of cell surface markers, which is tumor-type dependent. At present, the therapeutics related to oncology have evolved and exceeded the conventional therapies including the chemotherapy, radiotherapy, and surgeries, since all these have their certain limitations. This is anticipated to spur the market growth of CSCs. As per the journal released by the National Center for Biotechnology Information (NCBI) in September 2012, the clinical significance of CSCs has been reinforced by emerging evidence, demonstrating that CSCs are resistant to conventional chemotherapy and radiation treatment.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cancer-stem-cells-market

Further, CSCs are considered to be a key target for novel anti-cancer drug discovery. Thus, innovations in the field of oncology therapeutics are anticipated to augment the market growth. In the past couple of years, stem cells have been successfully utilized in immuno-reconstitution and for replenishment of blood after tumor development and at times, even after its treatment. In addition to this, these cells have gained substantial attention in the healthcare entities for its utilization as an effective tool in the delivery of anti-cancer agents along with the purpose of tissue regeneration.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered-

o             By Mode of Action

o             By Cancer Forms

  • Regions covered-

o             North America

o             Europe

o             Asia-Pacific

o             Rest of the World

  • Competitive Landscape:  Thermo Fisher Scientific, Inc., AbbVie Inc., and Merck KGaA, among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o             Deviation from the pre-COVID-19 forecast

o             Most affected region and segment

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Cancer Stem Cells Market Report by Segment

By Mode of Action

  • Stem-Cell Based Cancer Therapy
  • Targeted Cancer Stem Cell Therapy

By Cancer Forms

  • Breast Cancer
  • Blood Cancer
  • Lung Cancer
  • Brain Cancer
  • Others

A full report of Cancer Stem Cells (CSCs) Market is available at: https://www.omrglobal.com/industry-reports/cancer-stem-cells-market